J Pharm Res Int
Bland, absorbent, easy to digest
8.3 Eli Lilly - Narrow, Deep, Clinical-Asset-Anchored Lilly's estate (25 publications, 6 families) is much smaller in publication count than Sanofi's or Hanmi's, but its composition is concentrated on what matters for Retatrutide: explicit triple-agonist composition-of-matter claims, half-life extension chemistry (the fatty-acyl side chain architecture), formulation, and - notably - two publications in the oral delivery bucket
The flavonoid glycoside icariin has been shown to increase the expression of Nrf2, HO-1, and GPX4, in cisplatin-treated mouse ovarian tissues and KGN cells, which may contribute to reduced OS and ferroptosis (Li F
Another very-long-acting GLP-1RA is ZT002, a GLP-1 analogue with a C-terminal extension to increase stability and two C-18 fatty acid chains to increase attachment to albumin